Literature DB >> 9545141

Current management of human bites.

W F Bunzli1, D H Wright, A T Hoang, R D Dahms, W F Hass, J C Rotschafer.   

Abstract

Human bites should be considered dangerous injuries with potentially serious complications. Their characteristics vary from an uninfected abrasion to a serious infection such as cellulitis or osteomyelitis. An estimated 10% of the injuries become infected; suspected pathogens include oral and skin flora. Management consists of history and examination, wound care, surgical intervention if necessary, assessment of risk of disease transmission, and appropriate antibiotic prophylaxis or treatment. The best choice for oral or intravenous antibiotic therapy remains the combination of a beta-lactam antibiotic with a beta-lactamase inhibitor. Among the most serious human bites are clenched fist injuries, which often require surgical intervention and intravenous antibiotic therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9545141

Source DB:  PubMed          Journal:  Pharmacotherapy        ISSN: 0277-0008            Impact factor:   4.705


  4 in total

1.  Challenging Dogma: Optimal Treatment of the "Fight Bite".

Authors:  Carl M Harper; Arriyan Samandar Dowlatshahi; Tamara D Rozental
Journal:  Hand (N Y)       Date:  2019-02-27

2.  Factors associated with delay to emergency department presentation, antibiotic usage and admission for human bite injuries.

Authors:  Roland C Merchant; Christopher P Zabbo; Kenneth H Mayer; Bruce M Becker
Journal:  CJEM       Date:  2007-11       Impact factor: 2.410

3.  The human bite injury: a clinical audit and discussion regarding the management of this alcohol fuelled phenomenon.

Authors:  Francis P Henry; Elizabeth M Purcell; Patricia A Eadie
Journal:  Emerg Med J       Date:  2007-07       Impact factor: 2.740

4.  Human bite injuries to the head and neck: current trends and management protocols in England and Wales.

Authors:  Glyndwr W Jenkins; Robert Isaac; Shakir Mustafa
Journal:  Oral Maxillofac Surg       Date:  2018-01-14
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.